Description
Brenipatide 10mg × 10 vials
A research peptide compound studied as a dual GLP-1 and GIP receptor agonist, with interest in metabolic regulation, appetite-related pathways, glucose response, and broader metabolic support research.
Product Overview
- Compound: Brenipatide
- Strength: 10 mg per vial
- Injection type: Subcutaneous
- Frequency: Research protocol dependent
Reconstitution
Amount in vial: 10 mg
BAC water: 2 mL
Amount per unit: 50 mg per unit
Recommended Dose
50 mg to 150 mg
Equivalent to 10 to 30 units
Notes
Intramuscular injection. Single dose should not exceed 250 mg (50 units).
Disclaimer
This product is intended for research and informational purposes only.
Reviews
There are no reviews yet.